Surgical Hemostat Internal Tissue Sealant Adhesion Barrier Market by 2024
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global <strong>Market</strong> Study on <strong>Surgical</strong> <strong>Hemostat</strong>s,<br />
<strong>Internal</strong> <strong>Tissue</strong> <strong>Sealant</strong>s and <strong>Adhesion</strong> <strong>Barrier</strong>s:<br />
MEA Regional <strong>Market</strong> Anticipated to Witness 1.6X<br />
Growth over the Forecast Period
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Report Media Releases<br />
Global <strong>Surgical</strong> <strong>Hemostat</strong>s, <strong>Internal</strong> <strong>Tissue</strong> <strong>Sealant</strong>s and<br />
<strong>Adhesion</strong> <strong>Barrier</strong>s <strong>Market</strong> is Estimated to cross US$ 5,717 Mn<br />
<strong>by</strong> <strong>2024</strong><br />
The global surgical hemostats, internal tissue sealants and adhesion barriers<br />
market is set to cross US$ 5 Billion <strong>by</strong> <strong>2024</strong>, expanding at a CAGR of over 8% during the next<br />
eight years. North America will continue to lead the market, accounting for almost 47% share of<br />
the global market over the assessment period.<br />
Persistence <strong>Market</strong> Research (PMR) indicates that the global market will witness a steady<br />
growth owing to factors such as challenges before adhesive prevention, changing nature of<br />
clinical needs and higher caseload across the globe. In addition, key players operating in the<br />
global market are actively focusing on strategic collaborations in order to extend their product<br />
reach across narrower distribution channels. This, in turn, is anticipated to support the growth of<br />
market over the next couple of years. However, this steep increase in overall surgical procedures<br />
will not necessarily cover-up for the complications associated with adhesion and internal tissue<br />
sealants surgeries, as advanced minimally invasive surgical procedures have higher efficiency<br />
with reduced size and severity of surgical wounds.<br />
As per PMR’s report, the existence of handful established brands that are running globally and<br />
uneven structure of the market is expected to present lucrative market opportunities for local<br />
players over the forecast period.<br />
A Sample of this Report is Available Upon Request @<br />
http://www.persistencemarketresearch.com/samples/3417<br />
On the basis of product type, the hemostats product segment is estimated to reach a market<br />
valuation of US$ 2.2 Billion <strong>by</strong> the closing end of the assessment period. In terms of value, the<br />
segment is estimated to increase 1.9x over <strong>2024</strong> despite recording a relatively low CAGR.<br />
Whereas, demand for synthetic polymer based internal tissue sealants is expected to gain<br />
traction in the near future. This is primarily due to increased product offerings for tissue sealants<br />
<strong>by</strong> manufacturers leading to market exclusivity. Moreover, increasing focus on developing<br />
advanced surgical sealants and adhesion barriers owing to the inadequacy of hemostatic<br />
products such as oxidized regenerated cellulose based and gelatin based hemostats that are<br />
eventually reaching limitation. Demand for adhesion barriers surgeries is also poised to grow at a<br />
handsome pace, reflecting a CAGR of 9.2% between 2016 and <strong>2024</strong>.<br />
Based on end user, hospitals is anticipated to be the leading segment, expanding at over 9%<br />
CAGR over the assessment period. The segment will be benefited <strong>by</strong> the increasing availability<br />
of low cost procedures associated with the use of hemostats in various cases.<br />
Based on regional prospects, North America will retain the major share of the global market over<br />
<strong>2024</strong> followed <strong>by</strong> Europe. In addition, the market in North America is expected to create an<br />
incremental opportunity of closely to US$ 1,642 Million during 2016 to 2026. Europe being the<br />
second largest market is set to rake in US$ 1.2 Billion in revenues over <strong>2024</strong>, with the UK,<br />
Germany and France occupying the top three spots of the market in the region. A sharp rise in<br />
North America Wound Debridement Products <strong>Market</strong> <strong>by</strong> <strong>2024</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
the number of cardiovascular surgeries in countries such as China, Australia and Japan is<br />
expected to present lucrative market opportunities in the Asia Pacific region during the projected<br />
period. Moreover, rapid launch of new products and service extension of existing products in<br />
both APAC and Europe is a major factor expected to drive the growth prospects of the market in<br />
these regions.<br />
Request to View Tables of Content @ http://www.persistencemarketresearch.com/marketresearch/surgical-hemostat-internal-tissue-sealant-adhesion-barrier-market/toc<br />
Key player operating in the global market for surgical hemostats, internal tissue sealants and<br />
adhesion barriers market include Baxter international Inc., <strong>Tissue</strong>med Ltd., C.R. Bard Inc. (Davol<br />
Inc.), B. Braun Melsungen AG (Asculap), Ethicon Inc. (Johnson & Johnson), Cryolife Inc.,<br />
Cohera Medical, Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Sanofi, and CSL<br />
Behring (CSL Ltd.). Most of these companies are actively focusing on completing strategic<br />
mergers and acquisitions to achieve higher product penetration.<br />
Browse Complete Report @ http://www.persistencemarketresearch.com/marketresearch/surgical-hemostat-internal-tissue-sealant-adhesion-barrier-market.asp<br />
About Us:<br />
Persistence <strong>Market</strong> Research (PMR) is a third-platform research firm. Our research model is a<br />
unique collaboration of data analytics and market research methodology to help businesses<br />
achieve optimal performance.<br />
To support companies in overcoming complex business challenges, we follow a multi-disciplinary<br />
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying<br />
real-time data collection, big data, and customer experience analytics, we deliver business<br />
intelligence for organizations of all sizes.<br />
Our offerings include pre-built reports that address every major sale, customized solutions to<br />
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration<br />
research approach for exploring emerging technologies has allowed us to solve the<br />
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.<br />
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and<br />
provide the latest insights into these technologies when they are being commercialized. Our<br />
ground-breaking approach allows us to deliver market solutions before the technologies reach<br />
the market.<br />
North America Wound Debridement Products <strong>Market</strong> <strong>by</strong> <strong>2024</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing<br />
startups. PMR’s collaborative environment is committed to building industry-specific solutions <strong>by</strong><br />
transforming data from multiple streams into a strategic asset.<br />
Contact Us:<br />
Persistence <strong>Market</strong> Research<br />
90 Sate Street, Suite 700 Albany, NY 12207<br />
Tel: +1-518-618-1030<br />
Email: sales@persistencemarketresearch.com<br />
Website: http://www.persistencemarketresearch.com/<br />
media@persistencemarketresearch.com<br />
Stay updated with our official Blog: http://pmrblog.com<br />
North America Wound Debridement Products <strong>Market</strong> <strong>by</strong> <strong>2024</strong>